Dr Pepper Snapple downgraded to Sell from Neutral at Goldman

theflyonthewall.com

Goldman downgraded Dr Pepper Snapple due to lackluster results for the 10-calorie platform and a softer volume and pricing outlook for the industry. Price target lowered to $45 from $48.

View Comments (0)